These results show that Provigil is effective for reducing excessive daytime sleepiness in people with narcolepsy. People taking Provigil had lower sleepiness scores than people taking a placebo.

Solriamfetol is a dopamine and norepinephrine reuptake inhibitor, trace amine-associated receptor 1 agonist, and 5-HT 1A agonist. It is currently approved under the brand name Sunosi ® to improve ...

These results show that Nuvigil is effective for reducing excessive daytime sleepiness in people with narcolepsy. People taking Nuvigil had lower sleepiness scores than people taking placebo.

本综述深入探讨了发作性睡病（Narcolepsy）的临床表现、治疗策略及未来方向，强调需超越经典五联征进行综合管理。 发作性睡病（Narcolepsy）是一种罕见的慢性神经学疾病，其特征性症状包括白天过度嗜睡（Excessive Daytime Sleepiness, EDS）、猝倒（Cataplexy）、夜间 ...

Alkermes has begun a randomised Phase II trial to assess the efficacy and safety of ALKS 2680 in adults with idiopathic ...

This fragmented sleep architecture can result in excessive daytime sleepiness, multiple awakenings, fatigue, insomnia, spontaneous daytime dozing, and hallucinations. Narcolepsy is a life-long ...

Excessive daytime sleepiness (EDS) can be frustrating and ... Another sleep disorder is narcolepsy, a neurological condition that causes uncontrollable daytime sleep episodes.

Axsome Therapeutics AXSM announced top-line data from the phase III PARADIGM study, which evaluated solriamfetol for the ...

This symptom isn't serious and mostly occurs with narcolepsy type one — otherwise, it's very rare. A doctor can diagnose narcolepsy and prescribe medication to treat cataplexy and other symptoms.

Despite the typical depiction of narcolepsy, it's not only excessive daytime sleepiness. Those with narcolepsy also experience uneven and interrupted sleep patterns at night. If left untreated ...

A week after reporting a successful phase 3 trial of Sunosi (solriamfetol) in patients with attention-deficit/hyperactivity ...